Cargando…

Biomarker-Based Targeting of the Androgen-Androgen Receptor Axis in Advanced Prostate Cancer

Recent therapeutic advances for managing advanced prostate cancer include the successful targeting of the androgen-AR axis with several new drugs in castrate resistant prostate cancer including abiraterone acetate and enzalutamide (MDV3100). This translational progress from “bench to bed-side” has r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kohli, Manish, Qin, Rui, Jimenez, Rafael, Dehm, Scott M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432332/ https://www.ncbi.nlm.nih.gov/pubmed/22956944 http://dx.doi.org/10.1155/2012/781459

Ejemplares similares

Androgen receptor: Functional roles and facets of regulation in urology
por: Dehm, Scott M., et al.
Publicado: (2020)

Prostate Cancer Characteristics Associated with Response to Pre-Receptor Targeting of the Androgen Axis
por: Mostaghel, Elahe A., et al.
Publicado: (2014)

Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy?
por: Peinetti, Nahuel, et al.
Publicado: (2022)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope
por: Saranyutanon, Sirin, et al.
Publicado: (2019)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011)

The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer
por: Eisermann, Kurtis, et al.
Publicado: (2017)

Response to Androgens and Androgen Receptor Antagonists in the Presence of Cytokines in Prostate Cancer
por: Culig, Zoran
Publicado: (2021)

Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target
por: Asim, Mohammad, et al.
Publicado: (2015)

The Evolution of Prostate Cancer Therapy: Targeting the Androgen Receptor
por: Aragon-Ching, Jeanny B.
Publicado: (2014)

Androgen receptor-mediated upregulation of quaking affects androgen receptor-related prostate cancer development and anti-androgen receptor therapy
por: Zhang, Keke, et al.
Publicado: (2018)

Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer
por: Henzler, Christine, et al.
Publicado: (2016)

Prognostic association of plasma cell free DNA based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration resistant prostate cancer patients
por: Kohli, Manish, et al.
Publicado: (2018)

Loss and revival of androgen receptor signaling in advanced prostate cancer
por: Formaggio, Nicolò, et al.
Publicado: (2021)

Androgen Receptor-CaMKK2 Axis in Prostate Cancer and Bone Microenvironment
por: Dadwal, Ushashi C., et al.
Publicado: (2018)

Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer
por: Wen, Simeng, et al.
Publicado: (2020)

Metabolic Roles of Androgen Receptor and Tip60 in Androgen-Dependent Prostate Cancer
por: Tan, Kah Ni, et al.
Publicado: (2020)

Plasma Androgen Receptor in Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2019)

Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate Cancer
por: Ban, Fuqiang, et al.
Publicado: (2021)

Androgen receptor axis-targeted agents are not superior to conventional hormonal therapy for treatment of metastatic prostate cancer
por: Wada, Akinori, et al.
Publicado: (2022)

The androgen receptor—lncRNASAT1-AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells
por: Mirzakhani, Kimia, et al.
Publicado: (2021)

Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes
por: Olsen, Jan Roger, et al.
Publicado: (2016)

Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor
por: Rajamahanty, Srinivas, et al.
Publicado: (2010)

Identification of novel androgen receptor target genes in prostate cancer
por: Jariwala, Unnati, et al.
Publicado: (2007)

Overview on the complexity of androgen receptor-targeted therapy for prostate cancer
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2015)

Androgen Receptor-Directed Molecular Conjugates for Targeting Prostate Cancer
por: Beretta, Giovanni L., et al.
Publicado: (2019)

ROLE OF ANDROGEN RECEPTOR-TARGETED AGENTS IN LOCALIZED PROSTATE CANCER
por: Murgić, Jure, et al.
Publicado: (2022)

Androgen regulation of the androgen receptor coregulators
por: Urbanucci, Alfonso, et al.
Publicado: (2008)

Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer
por: Zadra, Giorgia, et al.
Publicado: (2019)

A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells
por: Li, Tzu-Huey, et al.
Publicado: (2007)

Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells
por: Izumi, Kouji, et al.
Publicado: (2019)

CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer
por: Hwang, Justin H., et al.
Publicado: (2019)

Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer
por: Denmeade, Samuel R, et al.
Publicado: (2023)

Maximal androgen blockade for advanced prostate cancer
por: Mukha, Rajiv Paul, et al.
Publicado: (2010)

Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy
por: Chen, Jia-Feng, et al.
Publicado: (2019)

Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer
por: Kahn, Barbara, et al.
Publicado: (2014)

Plasma androgen receptor and serum chromogranin A in advanced prostate cancer
por: Conteduca, Vincenza, et al.
Publicado: (2018)

Metformin and Androgen Receptor-Axis-Targeted (ARAT) Agents Induce Two PARP-1-Dependent Cell Death Pathways in Androgen-Sensitive Human Prostate Cancer Cells
por: Xie, Yi, et al.
Publicado: (2021)

Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes
por: Jillson, Lauren K., et al.
Publicado: (2021)

Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens
por: Dart, D. A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_0niorgefph3c65v6a6rdr7jhg1